It is time for a new comprehensive medication review quality measure

Authors

Melissa Castora-Binkley, Pharmacy Quality Alliance
Lisa Hines, Pharmacy Quality Alliance
Shannon Vaffis, Clinical Outcomes Solutions
Harman Dhatt, Janssen Pharmaceuticals, Inc.
Elizabeth Anderson, The Freedom Fund
Darlena Le, The University of Arizona
Heather Black, Merck & Co., Inc.
Patrick J. Campbell, Pharmacy Quality Alliance
Irina Kolobova, Merck & Co., Inc.
Mel Nelson, Pharmacy Quality Alliance
David R. Axon, The University of Arizona
Terri Warholak, The University of Arizona

Document Type

Article

Publication Title

Journal of Managed Care and Specialty Pharmacy

Abstract

Medication therapy management (MTM) services include comprehensive medication reviews (CMRs), which have been completed with millions of patients since their inception in the United States. The current MTM quality measure focuses on whether CMRs were completed (ie, the CMR completion rate). However, this process measure does not assess quality of care, or patient-reported or other outcomes of CMRs, and, therefore, does not reward MTM providers for improving health outcomes. In this viewpoint article, we present 3 reasons that shape our argument for new MTM quality measures and offer recommendations on next steps to achieve this.

First Page

680

Last Page

684

DOI

10.18553/jmcp.2023.29.6.680

Publication Date

6-1-2023

Recommended Citation

Castora-Binkley, Melissa; Hines, Lisa; Vaffis, Shannon; Dhatt, Harman; Anderson, Elizabeth; Le, Darlena; Black, Heather; Campbell, Patrick J.; Kolobova, Irina; Nelson, Mel; Axon, David R.; and Warholak, Terri, "It is time for a new comprehensive medication review quality measure" (2023). Pharmacy Practice Faculty Publications. 341. https://doi.org/10.18553/jmcp.2023.29.6.680
https://collections.uhsp.edu/pharm-practice_pubs/341